N/A
Manufactured by Accord Healthcare, Inc.
6 FDA adverse event reports analyzed
Last updated: 2026-04-15
METHYL SALICYLATE, MENTHOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Accord Healthcare, Inc.. The most commonly reported adverse reactions for METHYL SALICYLATE, MENTHOL include BACK PAIN, BLOOD PROLACTIN INCREASED, BREAST DISCHARGE, BREAST PAIN, RASH PRURITIC. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for METHYL SALICYLATE, MENTHOL.
Out of 1 classified reports for METHYL SALICYLATE, MENTHOL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 6 FDA FAERS reports that mention METHYL SALICYLATE, MENTHOL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include BACK PAIN, BLOOD PROLACTIN INCREASED, BREAST DISCHARGE, BREAST PAIN, RASH PRURITIC, REFUSAL OF TREATMENT BY PATIENT. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Accord Healthcare, Inc. in connection with METHYL SALICYLATE, MENTHOL. Always verify the specific product and NDC with your pharmacist.